Claims for Patent: 7,588,755

Summary for Patent: 7,588,755

Title:	DNA sequences, recombinant DNA molecules and processes for producing human fibroblast interferon-like polypeptides
Abstract:	DNA sequences, recombinant DNA molecules and hosts transformed with them which produce polypeptides displaying a biological or immunological activity of human fibroblast interferon, the genes coding for these polypeptides and methods of making and using these DNA sequences, molecules, hosts, genes and polypeptides. The DNA sequences are characterized in that they code for a polypeptide displaying a biological or immunological activity of human fibroblast interferon. In appropriate hosts these DNA sequences and recombinant DNA molecules permit the production and identification of genes and polypeptides displaying a biological or immunological activity of human fibroblast interferon and their use in antiviral and antitumor or anticancer agents.
Inventor(s):	Walter Charles Fiers
Assignee:	Biogen MA Inc
Application Number:	US08/449,930

Details for Patent 7,588,755

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Emd Serono, Inc.	REBIF	interferon beta-1a	Injection	103780	March 07, 2002		2026-09-15
Emd Serono, Inc.	REBIF	interferon beta-1a	Injection	103780	December 17, 2004		2026-09-15
Emd Serono, Inc.	REBIF	interferon beta-1a	Injection	103780	December 21, 2012		2026-09-15
Novartis Pharmaceuticals Corporation	EXTAVIA	interferon beta-1b	For Injection	125290	August 14, 2009		2026-09-15

International Patent Family for US Patent 7,588,755

Country	Patent Number	Estimated Expiration
Zimbabwe	11281
South Africa	813110
South Africa	812196
South Africa	812189